Breaking
Minor MedicineINT STAT

STAT+: Did the Trump administration just cut Novo a huge financial win?

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Dr. Oz praised GLP-1s from Eli Lilly’s lab…

Read the full story at STAT ↗

ImpactMinor 11/100
Why it mattersRule-based estimate: event keywords (+4), soft/evergreen signals; trust 8/10.
RegionsGlobal
Published4 h ago (Tue, 22 Sep 2026 16:23:21 GMT)
RetrievedTue, 22 Sep 2026 19:00:56 GMT via rss
ClassifiedTue, 22 Sep 2026 19:01:05 GMT by heuristic
AuthorJohn Wilkerson